Outcome and risk of hemorrhage in patients with tandem lesions after endovascular treatment: A propensity score-matched case-control study
- PMID: 36942245
- PMCID: PMC10024127
- DOI: 10.1016/j.heliyon.2023.e14508
Outcome and risk of hemorrhage in patients with tandem lesions after endovascular treatment: A propensity score-matched case-control study
Erratum in
-
Corrigendum to "Outcome and risk of hemorrhage in patients with tandem lesions after endovascular treatment: A propensity score-matched case-control study" [Heliyon Volume 9, Issue 3, March 2023, Article e14508].Heliyon. 2025 Mar 17;11(8):143233. doi: 10.1016/j.heliyon.2025.143233. eCollection 2025 Mar 31. Heliyon. 2025. PMID: 40534958 Free PMC article.
Abstract
Objectives: Endovascular treatment of acute stroke patients with large vessel occlusions is well established. But tandem lesions of the internal carotid artery and the intracranial anterior circulation remain a challenge regarding the technical conditions and the putative higher risk of hemorrhage due to often required antiplatelet therapy.This study aims to evaluate the clinical outcome and the risk of hemorrhage after endovascular treatment of tandem lesions, with special regard to the periprocedural antiplatelet regimen.
Materials and methods: In this retrospective study, we included 63 consecutive stroke patients with endovascular treated tandem lesions. One hundred eleven patients with a solitary intracranial occlusion were matched using a "propensity score-matched analysis" with the covariates sex, age, wake-up stroke, iv-thrombolysis and NIHSS.
Results: Rates of successful recanalization (mTICI 2b/3) and periprocedural complications were equal in both groups (P = 0.19; P = 0.35). The rate of good clinical outcome (mRS≤2) was similar, and the incidence of symptomatic hemorrhages was not significantly different (7.9% tandem lesions vs. 5.4% isolated intracranial occlusion, P = 0.51). Even intensified antiplatelet therapy in patients with tandem lesions did not increase the rate of symptomatic intracranial hemorrhages (P = 0.87).
Conclusions: Clinical outcome and symptomatic intracranial hemorrhages did not differ significantly between endovascular treated patients with tandem lesions and matched patients with solitary intracranial occlusions, regardless of the antiplatelet regimen. Therefore, the complex technical requirements for recanalization of a tandem lesion and the putative higher risk should not result in reluctant treatment that would decrease the chance of a good clinical outcome.
Keywords: Antiplatelet agents; Stenting; Stroke; Tandem occlusion; Thrombectomy.
© 2023 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- Berkhemer O.A., Fransen P.S., Beumer D., et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 2015;372:11–20. - PubMed
-
- Campbell B.C., Mitchell P.J., Kleinig T.J., et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N. Engl. J. Med. 2015;372:1009–1018. - PubMed
-
- Goyal M., Demchuk A.M., Menon B.K., et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N. Engl. J. Med. 2015;372:1019–1030. - PubMed
-
- Saver J.L., Goyal M., Bonafe A., et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. 2015;372:2285–2295. - PubMed
-
- Jovin T.G., Chamorro A., Cobo E., et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N. Engl. J. Med. 2015;372:2296–2306. - PubMed
LinkOut - more resources
Full Text Sources